<?xml version='1.0' encoding='utf-8'?>
<section article="ghg" article_name="Health - General" number="13-3501" title_number="13" title_name="Miscellaneous Health Care Programs" subtitle_number="35" subtitle_name="Co-Prescribing of Opioid Overdose Reversal Drugs">
  <level label="a">
    <text>In this subtitle the following words have the meanings indicated.</text>
  </level>
  <level label="b">
    <text>“Co–prescribing” means, with respect to an opioid overdose reversal drug, the practice of prescribing the drug in conjunction with an opioid prescription for a patient at an elevated risk of overdose.</text>
  </level>
  <level label="c">
    <text>“Opioid overdose reversal drug” means naloxone or a similarly acting and equally safe drug that is approved by the federal Food and Drug Administration for the treatment of a known or suspected opioid overdose.</text>
  </level>
</section>
